Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L van Doorn

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Plos One|March 31, 2015
Patient characteristics associated with measurement of routine diabetes care: an observational studyArna L Van Doorn-Klomberg, Jozé C C Braspenning, Femke Atsma, et al.
Scandinavian Journal of Primary Health Care|September 30, 2014
Organizational determinants of high-quality routine diabetes careArna L van Doorn-Klomberg, Jozé C C Braspenning, René J Wolters, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 28, 2006
Aggressive angiomyxoma: multimodality treatments can avoid mutilating surgeryI J M Han-Geurts, A N van Geel, L van Doorn, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|December 10, 2014
Paging through history: parchment as a reservoir of ancient DNA for next generation sequencingM D Teasdale, N L van Doorn, S Fiddyment, et al.
Climacteric : the Journal of the International Menopause Society|June 5, 2026
Leveraging STRAW +10 criteria to evaluate menopause stage effects on sleep qualityShelby C Wood, Jacob L van Doorn, Susan Y Bookheimer, et al.
Climacteric : the Journal of the International Menopause Society|May 2, 2024
Mental health during the COVID-19 pandemic: the importance of social support in midlife womenElizabeth S Wenzel, Jacob L Van Doorn, Rachel A Schroeder, et al.
Clinical Pharmacology and Therapeutics|July 19, 2013
Conjunctive therapy of cisplatin with the OCT2 inhibitor cimetidine: influence on antitumor efficacy and systemic clearanceJ A Sprowl, L van Doorn, S Hu, et al.
International Journal of Integrated Care|February 22, 2021
Physician Assistants and Nurse Practitioners in Primary Care Plus: A Systematic ReviewR M A van Erp, A L van Doorn, G T van den Brink, et al.
British Journal of Cancer|April 10, 2014
A phase I pharmacokinetic study of the vascular disrupting agent ombrabulin (AVE8062) and docetaxel in advanced solid tumoursF A L M Eskens, P Tresca, D Tosi, et al.
Biochimica Et Biophysica Acta|January 1, 2008
Cartilage-hair hypoplasia-associated mutations in the RNase MRP P3 domain affect RNA folding and ribonucleoprotein assemblyTim J M Welting, Sandy Mattijssen, Florence M A Peters, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Plos One|March 31, 2015
Patient characteristics associated with measurement of routine diabetes care: an observational studyArna L Van Doorn-Klomberg, Jozé C C Braspenning, Femke Atsma, et al.
Scandinavian Journal of Primary Health Care|September 30, 2014
Organizational determinants of high-quality routine diabetes careArna L van Doorn-Klomberg, Jozé C C Braspenning, René J Wolters, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 28, 2006
Aggressive angiomyxoma: multimodality treatments can avoid mutilating surgeryI J M Han-Geurts, A N van Geel, L van Doorn, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|December 10, 2014
Paging through history: parchment as a reservoir of ancient DNA for next generation sequencingM D Teasdale, N L van Doorn, S Fiddyment, et al.
Climacteric : the Journal of the International Menopause Society|June 5, 2026
Leveraging STRAW +10 criteria to evaluate menopause stage effects on sleep qualityShelby C Wood, Jacob L van Doorn, Susan Y Bookheimer, et al.
Climacteric : the Journal of the International Menopause Society|May 2, 2024
Mental health during the COVID-19 pandemic: the importance of social support in midlife womenElizabeth S Wenzel, Jacob L Van Doorn, Rachel A Schroeder, et al.
Clinical Pharmacology and Therapeutics|July 19, 2013
Conjunctive therapy of cisplatin with the OCT2 inhibitor cimetidine: influence on antitumor efficacy and systemic clearanceJ A Sprowl, L van Doorn, S Hu, et al.
International Journal of Integrated Care|February 22, 2021
Physician Assistants and Nurse Practitioners in Primary Care Plus: A Systematic ReviewR M A van Erp, A L van Doorn, G T van den Brink, et al.
British Journal of Cancer|April 10, 2014
A phase I pharmacokinetic study of the vascular disrupting agent ombrabulin (AVE8062) and docetaxel in advanced solid tumoursF A L M Eskens, P Tresca, D Tosi, et al.
Biochimica Et Biophysica Acta|January 1, 2008
Cartilage-hair hypoplasia-associated mutations in the RNase MRP P3 domain affect RNA folding and ribonucleoprotein assemblyTim J M Welting, Sandy Mattijssen, Florence M A Peters, et al.
Pageof 3